相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Th1/Th17 T cell Tissue-Resident Immunity Increases Protection, But Is Not Required in a Vaccine Strategy Against Genital Infection With Chlamydia trachomatis
Nina Dieu Nhien Tran Nguyen et al.
FRONTIERS IN IMMUNOLOGY (2021)
A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications
Furong Qin et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Parenteral vaccination protects against transcervical infection with Chlamydia trachomatis and generate tissue-resident T cells post-challenge
Nina Dieu Nhien Tran Nguyen et al.
NPJ VACCINES (2020)
Gamma Interferon Is Required for Chlamydia Clearance but Is Dispensable for T Cell Homing to the Genital Tract
Jennifer D. Helble et al.
MBIO (2020)
Chlamydia muridarum Induces Pathology in the Female Upper Genital Tract via Distinct Mechanisms
Heze Yu et al.
INFECTION AND IMMUNITY (2019)
Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial
Sonya Abraham et al.
LANCET INFECTIOUS DISEASES (2019)
Adjuvanted influenza vaccines
John S. Tregoning et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Protective effect of Vaccine Promoted neutralizing antibodies against the intracellular Pathogen Chlamydia trachomatis
Anja Weinreich Olsen et al.
FRONTIERS IN IMMUNOLOGY (2017)
The contribution of Chlamydia-specific CD8+ T cells to upper genital tract pathology
Kelly R. Vlcek et al.
IMMUNOLOGY AND CELL BIOLOGY (2016)
Induction of partial immunity in both males and females is sufficient to protect females against sexual transmission of Chlamydia
C. P. O'Meara et al.
MUCOSAL IMMUNOLOGY (2016)
A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enghances Chlamydia trachomatis Clearance
Alexander Badamchi-Zadeh et al.
FRONTIERS IN IMMUNOLOGY (2016)
Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein
Anja W. Olsen et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies
Alexander Badamchi-Zadeh et al.
PLOS ONE (2015)
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting
Lori Newman et al.
PLOS ONE (2015)
Evaluation of intra- and extra-epithelial secretory IgA in chlamydial infections
Charles W. Armitage et al.
IMMUNOLOGY (2014)
Divergent outcomes following transcytosis of IgG targeting intracellular and extracellular chlamydial antigens
Charles W. Armitage et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
CD8+ T Cells Define an Unexpected Role in Live-Attenuated Vaccine Protective Immunity against Chlamydia trachomatis Infection in Macaques
Norma Olivares-Zavaleta et al.
JOURNAL OF IMMUNOLOGY (2014)
Whole genome identification of C. trachomatis immunodominant antigens after genital tract infections and effect of antibiotic treatment of pigtailed macaques
Dorothy L. Patton et al.
JOURNAL OF PROTEOMICS (2014)
Current barriers, challenges and opportunities for the development of effective STI vaccines: Point of view of vaccine producers, biotech companies and funding agencies
Betty Dodet
VACCINE (2014)
CD4+ T Cells Are Necessary and Sufficient To Confer Protection against Chlamydia trachomatis Infection in the Murine Upper Genital Tract
David C. Gondek et al.
JOURNAL OF IMMUNOLOGY (2012)
Tumor Necrosis Factor Alpha Production from CD8+ T Cells Mediates Oviduct Pathological Sequelae following Primary Genital Chlamydia muridarum Infection
Ashlesh K. Murthy et al.
INFECTION AND IMMUNITY (2011)
Protective Immunity to Chlamydia trachomatis Genital Infection: Evidence from Human Studies
Byron E. Batteiger et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Risk of Sequelae after Chlamydia trachomatis Genital Infection in Women
Catherine L. Haggerty et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
T Cell Responses in the Absence of IFN-γ Exacerbate Uterine Infection with Chlamydia trachomatis
David C. Gondek et al.
JOURNAL OF IMMUNOLOGY (2009)
Role of T Lymphocytes in the Pathogenesis of Chlamydia Disease
Joseph U. Igietseme et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
CD4 and CD8 T Cell Responses to the M. tuberculosis Ag85B-TB10.4 Promoted by Adjuvanted Subunit, Adenovector or Heterologous Prime Boost Vaccination
Tara Elvang et al.
PLOS ONE (2009)
Preclinical safety assessments of UC781 anti-human immunodeficiency virus topical microbicide formulations
D. L. Patton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate) -: A novel adjuvant inducing both strong CMI and antibody responses
J Davidsen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2005)
Animal chlamydioses and zoonotic implications
D Longbottom et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2003)
Fc receptor regulation of protective immunity against Chlamydia trachomatis
T Moore et al.
IMMUNOLOGY (2002)
Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses
DJ Zhang et al.
INFECTION AND IMMUNITY (2000)
分享论文
